Response of blood flow to hyperthermia in human prostate tumors: Opportunities for enhanced radiation effect and drug delivery.
/in Hyperthermia, International Publications, Prostate Cancer /von 2014-07-31 / J Clin Oncol 32, 2014 (suppl 4; abstr 189)A phase I, open label, dose escalation and cohort expansion study to evaluate the safety and immune response to autologous dendritic cells (DC) transduced with AdGMCA9 (DC-AdGMCAIX) in patients with mRCC.
/in Dendritic Cells, Hypernephroma, International Publications /von 2014-07-31 / J Clin Oncol 32, 2014 (suppl 4; abstr 490)Pharmacological modulation of autophagy enhances Newcastle disease virus-mediated oncolysis in drug-resistant lung cancer cells
/in International Publications, Newcastle Disease Virus, NSCLC /von 2014-07-30 / BMC Cancer 2014 Jul;14:551Sorafenib and locoregional deep electro-hyperthermia in advanced hepatocellular carcinoma: A phase II study
/in Hepatocellular Carcinoma, Hyperthermia, International Publications /von 2014-07-24 / Oncol Lett 2014 Oct;8(4):1783-1787Vaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and/or preleukapheresis IFN-α in patients with metastatic melanoma: a randomised „proof-of-principle“ phase II study
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2014-07-22 / J Transl Med 2014 Jul;12:209Long overall survival after dendritic cell vaccination in metastatic uveal melanoma patients
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2014-07-17 / Am. J. Ophthalmol. 2014 Nov;158(5):939-47ISG12a mediates cell response to Newcastle disease viral infection
/in International Publications, Newcastle Disease Virus /von 2014-07-05 / Virology 2014 Aug;462-463:283-94Going viral with cancer immunotherapy
/in International Publications, Newcastle Disease Virus /von 2014-07-03 / Nat. Rev. Cancer 2014 Aug;14(8):559-67Noninvasive radiofrequency treatment effect on mitochondria in pancreatic cancer cells
/in Hyperthermia, International Publications, Pancreatic Cancer /von 2014-07-01 / Cancer 2014 Nov;120(21):3418-25
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution